• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

小鼠T细胞中T细胞受体的逆转录病毒转导

Retroviral transduction of T-cell receptors in mouse T-cells.

作者信息

Zhong Shi, Malecek Karolina, Perez-Garcia Arianne, Krogsgaard Michelle

机构信息

NYU Cancer institute, New York University School of Medicine, USA.

出版信息

J Vis Exp. 2010 Oct 22(44):2307. doi: 10.3791/2307.

DOI:10.3791/2307
PMID:21048669
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3185635/
Abstract

T-cell receptors (TCRs) play a central role in the immune system. TCRs on T-cell surfaces can specifically recognize peptide antigens presented by antigen presenting cells (APCs). This recognition leads to the activation of T-cells and a series of functional outcomes (e.g. cytokine production, killing of the target cells). Understanding the functional role of TCRs is critical to harness the power of the immune system to treat a variety of immunology related diseases (e.g. cancer or autoimmunity). It is convenient to study TCRs in mouse models, which can be accomplished in several ways. Making TCR transgenic mouse models is costly and time-consuming and currently there are only a limited number of them available. Alternatively, mice with antigen-specific T-cells can be generated by bone marrow chimera. This method also takes several weeks and requires expertise. Retroviral transduction of TCRs into in vitro activated mouse T-cells is a quick and relatively easy method to obtain T-cells of desired peptide-MHC specificity. Antigen-specific T-cells can be generated in one week and used in any downstream applications. Studying transduced T-cells also has direct application to human immunotherapy, as adoptive transfer of human T-cells transduced with antigen-specific TCRs is an emerging strategy for cancer treatment. Here we present a protocol to retrovirally transduce TCRs into in vitro activated mouse T-cells. Both human and mouse TCR genes can be used. Retroviruses carrying specific TCR genes are generated and used to infect mouse T-cells activated with anti-CD3 and anti-CD28 antibodies. After in vitro expansion, transduced T-cells are analyzed by flow cytometry.

摘要

T细胞受体(TCRs)在免疫系统中发挥着核心作用。T细胞表面的TCRs能够特异性识别抗原呈递细胞(APCs)呈递的肽抗原。这种识别会导致T细胞的激活以及一系列功能结果(如细胞因子产生、靶细胞杀伤)。了解TCRs的功能作用对于利用免疫系统的力量治疗各种免疫相关疾病(如癌症或自身免疫性疾病)至关重要。在小鼠模型中研究TCRs很方便,可通过多种方式实现。制作TCR转基因小鼠模型成本高且耗时,目前可用的数量有限。另外,可通过骨髓嵌合体产生具有抗原特异性T细胞的小鼠。这种方法也需要几周时间且需要专业知识。将TCRs逆转录病毒转导到体外激活的小鼠T细胞中是一种快速且相对容易的方法,可获得具有所需肽 - MHC特异性的T细胞。抗原特异性T细胞可在一周内产生并用于任何下游应用。研究转导的T细胞也直接应用于人类免疫治疗,因为用抗原特异性TCRs转导的人类T细胞的过继性转移是一种新兴的癌症治疗策略。在此,我们展示了一种将TCRs逆转录病毒转导到体外激活的小鼠T细胞中的方案。人类和小鼠的TCR基因均可使用。携带特定TCR基因的逆转录病毒被产生并用于感染用抗CD3和抗CD28抗体激活的小鼠T细胞。在体外扩增后,通过流式细胞术分析转导的T细胞。

相似文献

1
Retroviral transduction of T-cell receptors in mouse T-cells.小鼠T细胞中T细胞受体的逆转录病毒转导
J Vis Exp. 2010 Oct 22(44):2307. doi: 10.3791/2307.
2
Rapid re-expression of retrovirally introduced versus endogenous TCRs in engineered T cells after antigen-specific stimulation.在抗原特异性刺激后,工程化 T 细胞中逆转录病毒引入的与内源性 TCR 快速重新表达。
J Immunother. 2011 Mar;34(2):165-74. doi: 10.1097/CJI.0b013e318206a10c.
3
Gene transfer of human TCR in primary murine T cells is improved by pseudo-typing with amphotropic and ecotropic envelopes.通过使用嗜性和嗜亲性包膜进行假型化,可提高原代小鼠T细胞中人TCR的基因转移效率。
J Gene Med. 2007 Jul;9(7):561-70. doi: 10.1002/jgm.1047.
4
Molecular immunology lessons from therapeutic T-cell receptor gene transfer.从治疗性 T 细胞受体基因转移中获得的分子免疫学教训。
Immunology. 2010 Feb;129(2):170-7. doi: 10.1111/j.1365-2567.2009.03227.x.
5
Recognition of fresh human tumor by human peripheral blood lymphocytes transduced with a bicistronic retroviral vector encoding a murine anti-p53 TCR.用编码鼠抗p53TCR的双顺反子逆转录病毒载体转导的人外周血淋巴细胞对新鲜人肿瘤的识别
J Immunol. 2005 Nov 1;175(9):5799-808. doi: 10.4049/jimmunol.175.9.5799.
6
Introduction of Genetically Modified CD3ζ Improves Proliferation and Persistence of Antigen-Specific CTLs.基因修饰的 CD3ζ 可提高抗原特异性 CTL 的增殖和持久性。
Cancer Immunol Res. 2018 Jun;6(6):733-744. doi: 10.1158/2326-6066.CIR-17-0538. Epub 2018 Apr 13.
7
Engineering improved T cell receptors using an alanine-scan guided T cell display selection system.利用丙氨酸扫描引导的 T 细胞展示选择系统工程改造 T 细胞受体。
J Immunol Methods. 2013 Jun 28;392(1-2):1-11. doi: 10.1016/j.jim.2013.02.018. Epub 2013 Mar 13.
8
In vivo programming of tumor antigen-specific T lymphocytes from pluripotent stem cells to promote cancer immunosurveillance.从多能干细胞中对肿瘤抗原特异性 T 淋巴细胞进行体内编程以促进癌症免疫监视。
Cancer Res. 2011 Jul 15;71(14):4742-7. doi: 10.1158/0008-5472.CAN-11-0359. Epub 2011 May 31.
9
Characterization of T-cell receptors directed against HLA-A*01-restricted and C*07-restricted epitopes of MAGE-A3 and MAGE-A12.鉴定针对 MAGE-A3 和 MAGE-A12 的 HLA-A*01 限制性和 C*07 限制性表位的 T 细胞受体。
J Immunother. 2012 Nov-Dec;35(9):680-8. doi: 10.1097/CJI.0b013e31827338ea.
10
TCR gene-engineered T cell: limited T cell activation and combined use of IL-15 and IL-21 ensure minimal differentiation and maximal antigen-specificity.T 细胞受体基因工程化 T 细胞:有限的 T 细胞激活以及白细胞介素 15 和白细胞介素 21 的联合使用可确保最小的分化和最大的抗原特异性。
Mol Immunol. 2010 Apr;47(7-8):1411-20. doi: 10.1016/j.molimm.2010.02.022.

引用本文的文献

1
A pan-cancer atlas of therapeutic T cell targets.一份治疗性T细胞靶点的泛癌图谱。
bioRxiv. 2025 Jul 7:2025.01.22.634237. doi: 10.1101/2025.01.22.634237.
2
STAT5 Activation Enhances Adoptive Therapy Combined with Peptide Vaccination by Preventing PD-1 Inhibition.信号转导和转录激活因子5(STAT5)的激活通过防止程序性死亡受体1(PD-1)抑制作用增强了过继性疗法与肽疫苗接种相结合的效果。
Mol Cancer Ther. 2025 Mar 4;24(3):419-430. doi: 10.1158/1535-7163.MCT-24-0505.
3
In situ cell-surface conformation of the TCR-CD3 signaling complex.TCR-CD3信号复合物的原位细胞表面构象。

本文引用的文献

1
Lethal graft-versus-host disease in mouse models of T cell receptor gene therapy.T 细胞受体基因治疗的小鼠模型中的致命移植物抗宿主病。
Nat Med. 2010 May;16(5):565-70, 1p following 570. doi: 10.1038/nm.2128. Epub 2010 Apr 18.
2
Generation of T-cell receptor retrogenic mice.T细胞受体逆转录基因小鼠的产生。
Nat Protoc. 2006;1(1):406-17. doi: 10.1038/nprot.2006.61.
3
Enhanced antitumor activity of murine-human hybrid T-cell receptor (TCR) in human lymphocytes is associated with improved pairing and TCR/CD3 stability.人淋巴细胞中鼠-人杂交T细胞受体(TCR)抗肿瘤活性增强与配对改善及TCR/CD3稳定性提高有关。
EMBO Rep. 2024 Dec;25(12):5719-5742. doi: 10.1038/s44319-024-00314-3. Epub 2024 Nov 7.
4
Combined analysis of T cell activation and T cell-mediated cytotoxicity by imaging cytometry.通过成像细胞术分析 T 细胞激活和 T 细胞介导的细胞毒性。
J Immunol Methods. 2022 Jul;506:113290. doi: 10.1016/j.jim.2022.113290. Epub 2022 May 27.
5
is a microRNA safeguard for -induced inflammatory colon oncogenesis.是一种 microRNA 保护物,可防止 - 诱导的炎症性结肠致癌发生。
Elife. 2018 Dec 13;7:e39479. doi: 10.7554/eLife.39479.
6
Optimized retroviral transduction of mouse T cells for in vivo assessment of gene function.用于体内基因功能评估的小鼠T细胞的优化逆转录病毒转导
Nat Protoc. 2017 Sep;12(9):1980-1998. doi: 10.1038/nprot.2017.083. Epub 2017 Aug 31.
7
Improved Transgenic Mouse Model for Studying HLA Class I Antigen Presentation.用于研究 HLA I 类抗原呈递的改良转基因小鼠模型。
Sci Rep. 2016 Sep 16;6:33612. doi: 10.1038/srep33612.
8
Structural Model of the Extracellular Assembly of the TCR-CD3 Complex.TCR-CD3复合物细胞外组装的结构模型。
Cell Rep. 2016 Mar 29;14(12):2833-45. doi: 10.1016/j.celrep.2016.02.081. Epub 2016 Mar 17.
9
T-cell receptor α enhancer is inactivated in αβ T lymphocytes.T细胞受体α增强子在αβ T淋巴细胞中失活。
Proc Natl Acad Sci U S A. 2015 Apr 7;112(14):E1744-53. doi: 10.1073/pnas.1406551112. Epub 2015 Mar 23.
10
Specific increase in potency via structure-based design of a TCR.通过基于结构的T细胞受体设计实现效力的特异性增强。
J Immunol. 2014 Sep 1;193(5):2587-99. doi: 10.4049/jimmunol.1302344. Epub 2014 Jul 28.
Cancer Res. 2006 Sep 1;66(17):8878-86. doi: 10.1158/0008-5472.CAN-06-1450.
4
Cancer regression in patients after transfer of genetically engineered lymphocytes.基因工程淋巴细胞转移后患者的癌症消退。
Science. 2006 Oct 6;314(5796):126-9. doi: 10.1126/science.1129003. Epub 2006 Aug 31.
5
How T cells 'see' antigen.T细胞如何“识别”抗原。
Nat Immunol. 2005 Mar;6(3):239-45. doi: 10.1038/ni1173.
6
Poor immunogenicity of a self/tumor antigen derives from peptide-MHC-I instability and is independent of tolerance.自身/肿瘤抗原的免疫原性差源于肽-MHC-I的不稳定性,且与耐受性无关。
J Clin Invest. 2004 Aug;114(4):551-9. doi: 10.1172/JCI21695.
7
Correction of multi-gene deficiency in vivo using a single 'self-cleaving' 2A peptide-based retroviral vector.使用基于单个“自切割”2A肽的逆转录病毒载体在体内纠正多基因缺陷。
Nat Biotechnol. 2004 May;22(5):589-94. doi: 10.1038/nbt957. Epub 2004 Apr 4.
8
T cell receptor antagonist peptides induce positive selection.T细胞受体拮抗剂肽诱导阳性选择。
Cell. 1994 Jan 14;76(1):17-27. doi: 10.1016/0092-8674(94)90169-4.
9
Versatile retroviral vectors for potential use in gene therapy.
Gene Ther. 1994 Mar;1(2):136-8.
10
Derivation of a T cell hybridoma variant deprived of functional T cell receptor alpha and beta chain transcripts reveals a nonfunctional alpha-mRNA of BW5147 origin.缺乏功能性T细胞受体α和β链转录本的T细胞杂交瘤变体的衍生揭示了源自BW5147的无功能α-信使核糖核酸。
Eur J Immunol. 1989 Dec;19(12):2269-74. doi: 10.1002/eji.1830191214.